A Multicenter Phase II Trial of Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer
Latest Information Update: 27 Feb 2017
Price :
$35 *
At a glance
- Drugs Nimotuzumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Rectal cancer
- Focus Therapeutic Use
- 01 Mar 2015 Interim results (n=21) published in the International Journal of Colorectal Disease
- 21 Jul 2013 New trial record